Liposome-mediated IL-28 and IL-29 expression in A549 cells and antiviral effect of IL-28 and IL-29 on WISH cells

Acta Pharmacologica Sinica

Volumn 27, Issue 4, 2006, Pages 453-459

  Li, Ming Cai ^a   Wang, Hao Yang ^a   Wang, Hai Yan ^a   Li, Tao ^a   He, Shao Heng ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Antiviral agents; Gene expression; Human interleukin 28A protein; Human interleukin 28B protein; Human interleukin 29 protein; Liposomes

Indexed keywords

ALPHA2B INTERFERON; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 28; INTERLEUKIN 29; LIPOSOME; RNA; UNCLASSIFIED DRUG;

AMNION CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VESICULAR STOMATITIS VIRUS; VIRUS VECTOR; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINES; DNA, COMPLEMENTARY; EPITHELIAL CELLS; GENETIC VECTORS; HUMANS; INTERFERON ALFA-2B; INTERLEUKINS; LIPOSOMES; LUNG NEOPLASMS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFECTION; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 33645216365     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00292.x     Document Type: Article

References (28)

1. Sheppard P Kindsvogel W Xu W Henderson K Schlutsmeyer S Whitmore TE et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003 4 63 8.
2. Kotenko SV Gallagher G Baurin VV Lewis-Antes A Shen M Shah NK et al. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003 4 69 77.
3. Coccia EM Severa M Giacomini E Monneron D Remoli ME Julkunen I et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and l interferon as in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004 34 796 805.
4. Renauld JC. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003 3 667 76.
5. Kotenko SV. The family of IL10-related cytokines and their receptors: related, but to what extent Cytokine Growth Factor Rev 2002 13 223 40.
6. Dumoutier L Renauld JC. Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur Cytokine Netw 2002 13 5 15.
7. Langer JK Cutrone EC Kotenko SV. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev 2004 15 33 48.
8. Li M He S. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 2004 10 620 5.
9. Dumoutier L Lejeune D Hor S Fickenscher H Renauld JC. Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem J 2003 370 391 6.
10. Pestka S Krause CD Sarkar D Walter MR Shi Y Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004 22 929 79.
11. Fickenscher H Hor S Kupers H Knappe A Wittmann S Sticht H. The interleukin-10 family of cytokines. Trends Immunol 2002 23 89 96.
12. Dumoutier L Tounsi A Michiels T Sommereyns C Kotenko SV Renauld JC. Role of the interleukin-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/IFN-lambda 1: similarities with type I interferon signaling. J Biol Chem 2004 279 32269 74.
13. Ebner S Neyer S Hofer S Nussbaumer W Romani N Heufler C. Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: an alternative to standard buffy coats. J Immunol Methods 2001 252 93 104.
14. Kozak M. An analysis of 5′-noncoding sequences from 699 ver tebrate messenger RNAs. Nucleic Acids Res 1987 15 8125 48.
15. Kozak M. Pushing the limits of the scanning mechanism for initiation of translation. Gene 2002 299 1 34.
16. Sambrook J Fritsch EF Maniatis T. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor Cold Spring Harbor Laboratory Press 2001.
17. Altschul SF Gish W Miller W Myers EW Lipman DJ. Basic local alignment search tool. J Mol Biol 1990 215 403 10.
18. Schwickerath O Brouns G Thrasher A Kinnon C Roes J Casimir C. Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD. J Gene Med 2004 6 603 15.
19. Edelstein ML Abedi MR Wixon J Edelstein RM. Gene therapy clinical trials worldwide 1989-2004: an overview. J Gene Med 2004 6 597 602.
20. Oku N Yamazaki Y Matsuura M Sugiyama M Hasegawa M Nango M. A novel non-viral gene transfer system: polycation liposomes. Adv Drug Deliv Rev 2001 52 209 18.
21. Choi WJ Kim JK Choi SH Park JS Ahn WS Kim CK. Low toxicity of cationic lipid-based emulsion for gene transfer. Biomaterials 2004 25 5893 903.
22. Song D Wang HL Wang S Zhang XH. 5-Hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells are extracellular signal-regulated kinase pathway dependent. Acta Pharmacol Sin 2005 26 563 7.
23. Familletti PC Rubinstein S Pestka S. A convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol 1981 78 387 94.
24. Osterlund P Veckman V Siren J Klucher KM Hiscott J Matikainen S et al. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 2005 79 9608 17.
25. Brand S Beigel F Olszak T Zitzmann K Eichhorst ST Otte JM et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005 289 G960 8.
26. Meager A Visvalingam K Dilger P Bryan D Wadhwa M. Bio logical activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005 31 109 18.
27. Brand S Zitzmann K Dambacher J Beigel F Olszak T Vlotides G et al. SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Biochem Biophys Res Commun 2005 331 543 8.
28. Robek MD Boyd BS Chisari FV. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 2005 79 3851 4.